Canada markets closed

Aclaris Therapeutics, Inc. (8AT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.1140-0.0060 (-0.54%)
At close: 08:02AM CEST
Show:
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
31,249
31,249
29,752
6,761
6,482
Cost of Revenue
18,081
18,081
11,960
4,713
5,133
Gross Profit
13,168
13,168
17,792
2,048
1,349
Operating Expenses
Research Development
98,384
98,384
77,813
43,813
29,338
Selling General and Administrative
31,098
31,098
25,133
23,619
20,530
Total Operating Expenses
129,482
129,482
102,946
67,432
49,868
Operating Income or Loss
-116,314
-116,314
-85,154
-65,384
-48,519
Total Other Income/Expenses Net
27,466
27,466
-1,754
-25,481
-2,817
Income Before Tax
-88,848
-88,848
-86,908
-90,865
-51,336
Income Tax Expense
-367
-367
0
0
-182
Income from Continuing Operations
-88,481
-88,481
-86,908
-90,865
-51,154
Net Income
-88,481
-88,481
-86,908
-90,865
-51,015
Net Income available to common shareholders
-88,481
-88,481
-86,908
-90,865
-51,015
Basic EPS
-1.66
-1.27
-1.33
-1.60
-1.20
Diluted EPS
-1.66
-1.27
-1.33
-1.60
-1.20
Basic Average Shares
68,765
69,809
65,214
56,731
42,539
Diluted Average Shares
68,765
69,809
65,214
56,731
42,539